Pilot Study Comparing Early Conversion to Extended-Release Tacrolimus (ENVARSUS XR) to Immediate-Release Tacrolimus in Lung Transplant Recipients
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Lung Transplant
-
Age: Between 18 years - 75 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Participants who are age = 18 years
- Those who Received a lung or heart-lung transplant at NYU Langone Health
- Participants who will be able to convert to Envarsus XR within the first month post-transplant
- Participants who are able to provide written informed consent
You may not be eligible for this study if the following are true:
-
- Contraindication to tacrolimus due to allergic or adverse reactions
- Pregnant or nursing women
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.